Daniel E. Kolker

Array ( [id] => 4525311 [patent_doc_number] => 07951931 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'Nucleic acid encoding sodium channel SCN3A alpha subunits' [patent_app_type] => utility [patent_app_number] => 12/364166 [patent_app_country] => US [patent_app_date] => 2009-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 7 [patent_no_of_words] => 18089 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951931.pdf [firstpage_image] =>[orig_patent_app_number] => 12364166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564117 [patent_doc_number] => 20090136970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'NOGO RECEPTOR HOMOLOGUES AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 12/350544 [patent_app_country] => US [patent_app_date] => 2009-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13880 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136970.pdf [firstpage_image] =>[orig_patent_app_number] => 12350544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479475 [patent_doc_number] => 20090202432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS' [patent_app_type] => utility [patent_app_number] => 12/345650 [patent_app_country] => US [patent_app_date] => 2008-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 53535 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202432.pdf [firstpage_image] =>[orig_patent_app_number] => 12345650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5434963 [patent_doc_number] => 20090169549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'CONFORMATIONAL ISOMERS OF ALPHA-SYNUCLEIN, ANTIBODIES THERETO AND METHODS OF THEIR MANUFACTURE AND USE' [patent_app_type] => utility [patent_app_number] => 12/337753 [patent_app_country] => US [patent_app_date] => 2008-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17778 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169549.pdf [firstpage_image] =>[orig_patent_app_number] => 12337753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5538700 [patent_doc_number] => 20090220505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'METHODS OF INHIBITING AMYLOID TOXICITY' [patent_app_type] => utility [patent_app_number] => 12/336340 [patent_app_country] => US [patent_app_date] => 2008-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18784 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220505.pdf [firstpage_image] =>[orig_patent_app_number] => 12336340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5302859 [patent_doc_number] => 20090297511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE' [patent_app_type] => utility [patent_app_number] => 12/328740 [patent_app_country] => US [patent_app_date] => 2008-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 32236 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20090297511.pdf [firstpage_image] =>[orig_patent_app_number] => 12328740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545330 [patent_doc_number] => 20090155207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Use of Immunomodulatory Compounds for the Treatment of Transverse Myelitis, Multiple Sclerosis, and Other Disorders' [patent_app_type] => utility [patent_app_number] => 12/324728 [patent_app_country] => US [patent_app_date] => 2008-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15058 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155207.pdf [firstpage_image] =>[orig_patent_app_number] => 12324728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580577 [patent_doc_number] => 20090175923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'HUMANIZED ANTI-AMYLOID BETA ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/323682 [patent_app_country] => US [patent_app_date] => 2008-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 17536 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175923.pdf [firstpage_image] =>[orig_patent_app_number] => 12323682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5484925 [patent_doc_number] => 20090274690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system' [patent_app_type] => utility [patent_app_number] => 12/313515 [patent_app_country] => US [patent_app_date] => 2008-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 87 [patent_figures_cnt] => 87 [patent_no_of_words] => 63803 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12313515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324193 [patent_doc_number] => 20090062183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Modulation of synaptogenesis' [patent_app_type] => utility [patent_app_number] => 12/291133 [patent_app_country] => US [patent_app_date] => 2008-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17177 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062183.pdf [firstpage_image] =>[orig_patent_app_number] => 12291133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5501679 [patent_doc_number] => 20090162367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Nucleotide and protein sequences of Nogo genes and methods based thereon' [patent_app_type] => utility [patent_app_number] => 12/290316 [patent_app_country] => US [patent_app_date] => 2008-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 11454 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162367.pdf [firstpage_image] =>[orig_patent_app_number] => 12290316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4563378 [patent_doc_number] => 07846679 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-07 [patent_title] => 'Methods for detecting the presence of mutant mammalian presenilin protein' [patent_app_type] => utility [patent_app_number] => 12/259668 [patent_app_country] => US [patent_app_date] => 2008-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 23498 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 210 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/846/07846679.pdf [firstpage_image] =>[orig_patent_app_number] => 12259668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564563 [patent_doc_number] => 20090137416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Isolating Cells Expressing Secreted Proteins' [patent_app_type] => utility [patent_app_number] => 12/240541 [patent_app_country] => US [patent_app_date] => 2008-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14894 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137416.pdf [firstpage_image] =>[orig_patent_app_number] => 12240541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5575431 [patent_doc_number] => 20090142793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'SCREENING ASSAY TO IDENTIFY MODULATORS OF THE SLEEP/WAKE CYCLE' [patent_app_type] => utility [patent_app_number] => 12/236374 [patent_app_country] => US [patent_app_date] => 2008-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30490 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142793.pdf [firstpage_image] =>[orig_patent_app_number] => 12236374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480658 [patent_doc_number] => 20090203615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'USE OF ACTIVITY DEPENDENT NEUROTROPHIC FACTOR FOR ENHANCING LEARNING AND MEMORY: PRE-AND POST-NATAL ADMINISTRATION' [patent_app_type] => utility [patent_app_number] => 12/197986 [patent_app_country] => US [patent_app_date] => 2008-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 20783 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203615.pdf [firstpage_image] =>[orig_patent_app_number] => 12197986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4623802 [patent_doc_number] => 08003097 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-23 [patent_title] => 'Treatment of cerebral amyloid angiopathy' [patent_app_type] => utility [patent_app_number] => 12/181238 [patent_app_country] => US [patent_app_date] => 2008-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 29542 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/003/08003097.pdf [firstpage_image] =>[orig_patent_app_number] => 12181238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7687577 [patent_doc_number] => 20090176714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'METHOD OF REDUCING THE EFFECTS OF ABeta AND COMPOSITIONS THEREFORE' [patent_app_type] => utility [patent_app_number] => 12/171011 [patent_app_country] => US [patent_app_date] => 2008-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22952 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176714.pdf [firstpage_image] =>[orig_patent_app_number] => 12171011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5361582 [patent_doc_number] => 20090036376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'Treatment for Anxiety' [patent_app_type] => utility [patent_app_number] => 12/165983 [patent_app_country] => US [patent_app_date] => 2008-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11544 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20090036376.pdf [firstpage_image] =>[orig_patent_app_number] => 12165983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5295968 [patent_doc_number] => 20090010894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'METHODS AND SYSTEMS FOR IDENTIFYING COMPOUNDS THAT MODULATE ALPHA-SYNUCLEIN AGGREGATION' [patent_app_type] => utility [patent_app_number] => 12/147402 [patent_app_country] => US [patent_app_date] => 2008-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12314 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20090010894.pdf [firstpage_image] =>[orig_patent_app_number] => 12147402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5309760 [patent_doc_number] => 20090017041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Monoclonal antibody' [patent_app_type] => utility [patent_app_number] => 12/213007 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 32779 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20090017041.pdf [firstpage_image] =>[orig_patent_app_number] => 12213007 [rel_patent_id] =>[rel_patent_doc_number] =>)